Could a new ALS therapy speed up treatment approval?
A new ALS therapy may qualify for faster FDA approval, potentially benefiting patients by addressing nerve cell damage sooner.
The whole archive, filed by the part of life it belongs to — and labelled with how strong the evidence behind it actually is.
Showing 1441–1464 of 3,535
A new ALS therapy may qualify for faster FDA approval, potentially benefiting patients by addressing nerve cell damage sooner.
Recordati's financial report highlights growth in rare disease treatments, with promising new therapies in development.
Recordati's strong Q1 2026 results highlight advancements in rare disease treatments.
A new online calculator helps adults find their daily protein needs for better health.
Longer life expectancy poses new risks, including healthcare access and financial planning challenges.
COSRX's new serum promotes skin health and resilience, focusing on longevity rather than just anti-aging.
ATUM's new platform may lead to more effective treatments for diseases.
The Sacramento Kings and Sutter Health are partnering to improve community health through sports and wellness programs.
A new AI tool helps create reliable reviews of longevity treatments.
Eli Lilly's new initiative aims to provide 500,000 meals and improve food access through cold storage at pantries.
New technology aims to use tiny particles in blood for early cancer detection.
Training your sense of smell may improve memory and mood, especially as you age.
GLP-1 drugs may cause muscle loss similar to regular dieting, but strength remains largely unaffected.
Updated guidelines offer new insights for managing advanced prostate cancer.
Revumenib shows promise in treating acute leukemia, potentially improving recovery rates after stem cell transplants.
The urinalysis market is growing, improving early detection of health issues, especially for older adults.
A new platform connects people to mental health providers in real-time, improving access and reducing dropout rates.
Telemedicine is improving stroke care in rural hospitals, allowing faster access to specialists and better outcomes.
A new partnership aims to use AI and real-world data to enhance healthcare delivery and improve patient outcomes.
A study shows RYTELO may help patients with blood cancer reduce transfusions.
Two new CAR-T cell therapies show promise for treating blood cancers.
A new investment aims to enhance care for people with limb-girdle muscular dystrophy, improving access and coordination in treatment.
A new blood test shows promise for early lung cancer detection in high-risk adults.
A new therapy shows promise for treating end-stage liver disease by reducing inflammation and fibrosis, but more research is needed in humans.